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Abstract 
Heart  failure  (HF)  is  a  clinical  syndrome that  is  the  last  common stage  in  many
cardiovascular  diseases.  The  main  causes  leading  to  the  development  of  HF are,  among
others,  primary  impairment  of  myocardial  contractility,  volume  and  /  or  ventricular
congestion, and obstruction of the diastolic duct due to pericardial diseases. The methods of
detecting heart failure include: an accurate interview with the patient, laboratory tests and
echocardiography.  Treatment  options  include  non-pharmacological,  pharmacological  and
surgical treatment. A very important aspect of cure is also physical activity and appropriate
nutritional treatment.
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Introduction 
Heart  failure  (HF)  is  a  clinical  condition  during  which  metabolic  disorders  and
functions of many organs occur due to abnormalities in the structure and function of the heart
[1]. The etiological factors of HF include: ischemic heart disease, hypertension, various heart
defects, prolonged arrhythmia, pericardial disease, but also aging [2]. HF is one of the most
frequent causes of hospitalization of elderly people with the highest risk of death [3]. The
phenomenon of the dual aging process that we can observe in the 21st century describes the
fact  that  the population lives  longer  and at  the same time increases  the number  of  older
people over the age of 85. What causes the increasing involvement of all areas of medicine in
the treatment and care of geriatric patients. Treatment of HF in older people is in many cases
very  difficult  due  to  the  presence  of  comorbidities.  The  Framingham Heart  Study  study
showed that the prevalence of HF increases markedly with age. In the group of 50-year-olds
it is 1%, while among 80-year-olds it is 10% [4]. In all age groups, women more often suffer
from heart failure [5].
Heart failure - definition, epidemiology, etiology
Heart failure (HF) is a clinical  syndrome that  is the final  common stage of many
cardiovascular diseases. According to Collucia and Braunwald, it is a pathological condition
in which the heart  cannot  pump blood in such quantity  that  it  would meet  the metabolic
demand of tissues, or it is able to do so with increased filling pressure. The most common
symptoms are dyspnoea at rest or exercise, night cough, night paroxysmal dyspnoea, edema
of the distal parts of the lower limbs, reduction of tolerance to physical exertion, fatigability.
Physical examination may include widened jugular veins, crepitations or rales over the lungs,
peripheral edema - around the cross, crotch. The existence of morphological and functional
abnormalities  in  the  resting  heart  such as  the  third  heart  tone,  enlargement  of  the  heart,
occurring  murmur  in  the  heart,  ECG  abnormalities  or  elevated  natriuretic  peptide
concentration are assumed to be objective data indicative of HF [6,7].
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The main causes leading to the development of HF include, among others, loss of
muscle  mass  and  primary  impairment  of  myocardial  contractility,  volumetric  and/or
ventricular congestion, and obstruction of diastole due to pericardial  diseases. Rarely,  the
reason for the presence of HF are arrhythmias, anemia, kidney failure, thyroid disease, or the
use of cardiodepressive drugs. However, they can lead to exacerbation of already existing
heart  failure.  Based  on  data  from  the  Framingham  study,  it  can  be  concluded  that
hypertension  is  the  most  common  cause  of  HF.  It  was  considered  that  it  preceded  the
development of HF in 75% of cases, and coronary heart disease was the cause of HF in about
50% of patients. The hypertrophy of the left ventricle and diabetes mellitus correlated well
with  the  development  of  HF.  In  90%  of  HF  cases  in  the  Framingham  population,  the
development was related to hypertension and ischemic heart disease, which occurred jointly
or alone [6,8].
In the classification of heart failure the most important is its division into systolic and
diastolic,  taking  into  account  the  degree  of  left  ventricular  dysfunction.  A  characteristic
feature of systolic heart  failure is reduced left  ventricle ejection fraction (EF). In systolic
failure, the left ventricle is enlarged and its walls are thinner, which causes a weakening of
the contraction force, and as a result, the ejection fraction is unable to press the appropriate
amount of blood that is necessary to maintain the correct cardiac output. In diastolic heart
failure, the left ventricle is normal or slightly lowered, but due to the hypertrophy and / or
stiffening of the left ventricular walls, the end-diastolic dimension of the ejection fraction is
reduced. Which results in a reduction, stiffening of the left ventricle, making it unable to
fulfill the required volume to ensure a correct cardiac output [6,9].
In  order  to  assess  the  severity  of  heart  failure  in  medical  practice,  the  HF
classification according to the New York Heart Association (NYHA) - the New York Heart
Association is most often used. This division is based on the assessment of the severity of
symptoms and exercise capacity.  According to NYHA, heart  failure is  grouped into four
classes. In patients in class I, normal physical activity does not contribute to greater fatigue,
there is no dyspnoea or palpitation. Class II - the disease slightly limits physical activity, does
not cause health problems at rest, but after the usual physical effort, patients feel tiredness,
palpitations, shortness of breath or coronary pain. Class III - there is a significant reduction in
physical  activity  without  rest  discomfort,  but  less  than normal  activity  causes  symptoms.
Class IV - the disease prevents any effort, any kind of physical activity causes problems even
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at  rest.  Class  IV  -  the  disease  prevents  any  effort,  any  kind  of  physical  activity  causes
problems even at rest [8,9].
In the Framingham Heart Study, the incidence of HF increases with age and in the
group of 50-year-olds is 1%, while among 80-year-olds it is already 10%. Women are more
likely to get ill in all age groups. The increasing stiffness of blood vessels and walls of the
left ventricle, endothelial dysfunction, impaired relaxation, as well as increased activity of
inflammatory processes leading to myocardium fibrosis favor the development of HF. Reflex
control disorders and cardiac arrhythmias are more common (eg atrial fibrillation). Therefore,
in people over 65, HF is not only one of the most common, but also the most expensive
reasons for hospitalization, with a high risk of death. Although HF often occurs in the elderly,
there is no binding data on the proper diagnosis and effective treatment  of this  group of
patients. Patients over 70 years of age are less frequently included in clinical trials, and their
treatment is hampered by co-morbidities [8,9,5].
Heart failure is a disease entity with very poor prognosis. HF prognosis is primarily
determined by the clinical condition of the patient. Indicators of 5-year survival in HF are
worse than survival rates of people with cancer (except for lung cancer), because in advanced
HF (NYHA class IV) about 50% of patients die within one year. This is justified by the
results of both European and American research. The prognosis in HF is closely related to the
degree  of  advancement  determined  according  to  the  NYHA  functional  classification.
Depending on the severity of the disease, the annual survival rate of patients is 40-80%. The
annual mortality rate, which depends on the symptoms of HF, according to NYHA, is as
follows:
● class I (patients without symptoms) - mortality up to 10%;
● class II (patients with minor symptoms during moderate physical exertion) - mortality
10-20%;
● class III (patients with HF symptoms during a small effort) - mortality 20-40%
● class IV (patients with rest dyspnoea) - mortality 40-60% [8,10].
The literature reports that over half of patients with full-blown HF die within 4 years
of follow-up, while 80% of men and 66% of women die after 10 years of illness [6,7].  
Pharmacological treatment
Pharmacological  treatment  of heart  failure aims to  improve the clinical  condition,
exercise capacity, quality of life, prevention of hospitalization, as well as reducing mortality
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[11]. It was found that the improvement of the above factors is an important indicator of the
effectiveness  of  therapy.  Pharmacological  treatment  uses  antagonists  of  neurohormonal
systems, e.g. ACEI (angiotensin converting-enzyme inhibitors),  MRA (mineralocorticoid /
aldosterone receptor antagonists) and LBA (β-blockers), so they allow survival in patients
with HFrEF heart failure with reduced ejection fraction)  and are recommended for everyone
who has no contraindications [12].
ACEIs should be increased gradually until adequate inhibition of the renin-angitensin-
aldosterone system (RAAS) is achieved.  These drugs should also be used in people with
asymptomatic LV systolic dysfunction. LBA therapy is used in stable patients. Initially, very
low doses are administered, gradually increasing them to the maximum tolerated by the body.
This type of treatment should be implemented very carefully. These drugs should be used in
people who have had MI and asymptomatic LV systolic dysfunction. The aim is to reduce the
risk  of  death  and  improve  functioning  in  everyday  life.  Administration  of  MRA
(spironolactone  and  eplerenone)  aims  to  block  aldosterone-binding  receptors  and  other
receptors  that  bind  hormones,  e.g.  corticosteroids,  androgens.  When  using  this  type  of
pharmacotherapy,  special  care  should  be  taken  in  people  with  impaired  renal  function
[12,13].
In ambulatory patients who, despite full therapy, have failed to achieve satisfactory
treatment results, as a replacement for ACEI, a combination of sacubitril  and valsartan is
used.  In  this  type  of  treatment,  inhibition  of  neprilesin  reduces  the  distribution  of  NP,
bradykinin  and  peptides,  which  increases  the  relaxation  of  the  myocardium,  inhibits
remodeling, as well as the secretion of renin and aldosterone [14].
 In  order  to  reduce  the  symptoms  of  stasis,  diuretics  are  used,  e.g.  furosemide,
bumetanide, torasemide, bendroflumetiazide, hydrochlorothiazide, metolazone, indapamide,
spironolactone / eplerenone, amiloride, triamteren [13]. These drugs are selected individually,
and their choice depends on the clinical condition of the patient. In patients with sinus rhythm
the invabadine, which is an inhibitor of the If channel, may also be used.
 It reduces HR by inhibiting the If channels in the sinus node. Digoxin should also be
used to reduce symptoms, and the use of this medicine should be particularly controlled in
women, as well as in elderly patients and people with impaired renal function. Digoxin can
be used as well as other digitalis and n-3 polyunsaturated fatty acids [12,15].
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Surgery
There are many surgical methods for treating heart failure in the elderly. In the last
decades, a significant increase in surgical treatment of heart failure has been observed.This
development  is  conditioned  by  the  lack  of  satisfactory  results  in  the  pharmacological
treatment of patients with advanced disease.
Orthotopic heart transplantation is a common curative treatment with a very good long-term
effect [16]. The main cause of heart failure with impaired left ventricular function is coronary
artery disease.  This is   about 30 % of patients  considered for heart  transplantation.  [17].
Unfortunately, the immunosuppressive treatment that is associated with heart transplantation
does not remain indifferent to the body. The effect of using drugs can be tumor incidence and
chronic vascular transplant disease.
In treating  heart  failure,  stem cells  are  also used to  stimulate  the development  of
cardiomyocytes in damaged myocardium [18]. Bone marrow stem cells are used to treat heart
failure. They are to replace the damaged tissue with a new healthy tissue.
In the case of ischemic heart failure, ais applied, which may improve the patient's clinical
condition and reduce the severity of the disease [19].
In surgical  treatment  of heart  failure, cardiac  resynchronization  therapy  (CRT) is
used,  especially  in  the  case  of  advanced  systolic  HF.  Due  to  abnormal  intraventricular
conduction, there is a lack of synchronous ventricular contraction. This situation occurs in
about 30% of patients  [20].  This clinical  situation may lead to further  impairment  of the
cardiac systolic function and its minute capacity.  Current indications for CRT are NYHA
functional class III to IV, LV ejection fraction <35%, and a QRS duration> 120 ms [21].
There are many methods for the treatment of surgical heart failure, some of them at
the  stage  of  clinical  trials.  In  the  last  decades,  this  field  has  been  developing  very
dynamically.
Nutrition in heart failure
The period after cardiac surgery is a good time to change eating habits in order to
reduce body mass and correct any irregularities. American Heart Associations recommends
base your diet on vegetables and fruits, both fresh and frozen, or from a can, but without the
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addition of sugar, salt and high-calorie sauces. The same organization recommends whole
grain  mill  products,  poultry  and  skinless  fish.  Particular  attention  is  paid  in  the
recommendations on the amount of consumed table salt. When recommending products with
low sodium content, limiting the daily intake of sodium to 1500 mg is a desirable habit and
helps lower blood pressure [22].
The most similar diet to the correct nutritional recommendations turns out to be the
Mediterranean diet. In the Seven Countries Study, it has been proven that the longest life time
and the lowest frequency of cardiovascular disease are characterized by inhabitants of areas
located  on  the  Mediterranean  Basin.  However,  the  highest  percentage  of  ischemic  heart
disease related to the population from Finland, the Netherlands and the United States, what is
more, in these countries the highest consumption of animal fats rich in saturated fatty acids
was observed [23].
In Poland in the  90s  of  the  last  century,  mortality  due to  cardiovascular  diseases
decreased  by  32%  on  average  in  both  sexes,  which  is  largely  associated  with  the
improvement  of  the  dietary  habits  of  Poles.  Consumption  of  fruit  increased  by  75%,
vegetable fat by 100% (which means increased consumption of mono- and polyunsaturated
fatty acids, vitamins and flavonoids), and butter consumption decreased by 47%, while other
animal fats - by 16% (which means decrease in consumption of saturated fatty acids) [24].
In  addition  to  the  basic  principles  of  rational  nutrition,  it  is  worth  mentioning
individual  vitamins  and  minerals.  Noteworthy  is  vitamin  B12  and  folic  acid,  whose
metabolism is  associated  with the  reduction  in  the body of  homocysteine.  The increased
concentration of this amino acid contributes to atherosclerosis of the coronary and peripheral
arteries, and increases the risk of stroke [25].
Another vitamin worth attention is vitamin E, whose increased intake reduces the risk
of heart attack by as much as 77% [26]. Researchers also pay attention to the intake of dietary
fiber.  It  is  the basis  of diet  in obesity,  diabetes,  cardiovascular  diseases.  Epidemiological
studies have shown a relationship between increased dietary fiber and the risk of ischemic
heart disease [27].
Kinesitherapy in heart failure
The stable clinical picture of heart  failure is not indicated as a contraindication to
physical activity of older people. On the contrary, properly selected activity is an important
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point of rehabilitation. Pre-diagnosis is important in physiotherapy. It allows you to choose
the right intensity of exercise.  Each training should be preceded by an assessment of the
patient's  clinical  condition.  Patients  with  heart  failure,  depending  on  the  severity  of  the
disease,  are  characterized  by  reduced  physical  capacity.  In  the  advanced  stage  we  use
exercises of low intensity and short duration, gradually increasing their frequency. On the
other hand, in people with better performance, we choose exercises of greater intensity and
longer  duration.  When  planning  a  rehabilitation  process,  contraindications  to  the  use  of
physical exercise should be taken into account [28,12,29].
Contraindications [28,29]:
● Relative contraindications:
○ 4th class NYHA
○ pulse at rest> 100 / min
○ decrease in systolic pressure during effort
○ shortness of breath at rest
● Absolute contraindications:
○ heart attack in the last 3 weeks
○ acute post-cardiac disease or fever
○ acute endocarditis, myocarditis or pericardium
○ fresh atrial fibrillation
To properly  plan  the  rehabilitation  process,  a  preliminary  diagnosis  should  be  made.  To
assess the patient's condition, the physiotherapist may use a 6-minute walk test (6 MWT), an
ergospirometric test, an exercise test. Based on the parameters assessed, the patient can be
qualified for the appropriate rehabilitation model. Depending on the severity of the disease
and  physical  capacity,  patients  can  be  divided  into  three  groups.  Qualification  to  the
appropriate group is based on the peak oxygen absorption and the result in 6 MWT [29].
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Tab.1. Classification of patients due to physical fitness [29].
Group 1 Group 2 Group 3
Impaired physical 
capacity
Moderately impaired
physical capacity
Good tolerance of 
physical exercise
Peak oxygen 
absorption
≤ 10 ml/kg/min > 10 ≤ 18 
ml/kg/min
> 18 ml/kg/min
Distance in 6 MWT < 300 m > 300 < 450 m > 450 m
After qualifying patients to the appropriate group, we use the following training
parameters.
The duration of the 
effort
Initially 5 -10 
minutes; target 30 - 
45 minutes
Initially 10-15 
minutes; target 45-60
minutes
Initially 15-20  
minutes; target 45-60
minutes
Target heart rate 40-60% heart rate 
reserve
50-70 % heart rate 
reserve
60-80%  heart rate 
reserve
In the training of patients with HF we use:
● endurance training,
● resistance training,
● breathing exercises.
Endurance training
Endurance  training  is  called  aerobic  or  aerobic  training.  Its  essence  is  dynamic
exercises  that  involve  large  muscle  groups.  Aerobic  training  is  the  basis  for  cardiac
rehabilitation. One of the basic forms of training is walking training. It is popular for its ease
of implementation and low cost. Training starts with a 40-50% load of top oxygen absorption
(VO2max). At low physical performance,  a walking speed of 50 m/min is recommended,
while at good efficiency 100 m/min. The modification of walking training is Nordic Walking.
Another  commonly  used  form of  training  is  training  on  a  cycloergometer.  The  interval
method is recommended. The working time should last from 30 seconds to 4 minutes, while
the time of  "return" should be 1-3 minutes.  During the "return"  the patient  should pedal
without load.
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As  a  result  of  training,  the  blood  flow  through  the  muscles  increases.  There  is  an
improvement in oxygen uptake by working muscles. Exercise also has a beneficial effect on
endothelial  function,  which  is  particularly  advantageous  because  endothelial  dysfunction
occurs in ischemic disease [28, 29 ,30].
Resistance training
Resistance training is also called strength training. Its purpose is to increase muscle
mass and strength. In the course of heart failure there is a reduction in physical performance,
therefore we observe a reduction in muscle mass. Properly selected training improves muscle
strength and endurance. We implement the resistance exercises after at least a week of using
well-tolerated endurance training. It is recommended to engage small muscle groups of one
limb alternately with the other limb. Strength training for older people with NS is composed
of two series of about 8 exercises each series. We do the training 2-3 times a week, initially
involving about 30% -50% of the maximum muscle strength [28,29,30].
Breathing exercises
Breathing  exercises  are  an  essential  element  of  any  rehabilitation  process.  In  the
course of heart  failure,  respiratory  function disorders  occur.  These exercises  improve the
mechanics  of breathing.  We start  the training with the intensity of 30% of the maximum
inspiratory pressure (PImax). The intensity is gradually increased, so as to reach the value of
60% PImax. It is recommended that the training takes 20-30 minutes a day. During the week,
2-3 training sessions should be performed. The recommended exercises  include:  resisting
diaphragm and abdominal muscle exercises, breathing exercises, exercises with the use of
special equipment [29,30].
Discussion
The  aim  of  the  study  was  to  present  therapeutic  progress.  In  patients  with  heart
failure, there are bad prognosis. Unfortunately, research confirms that half of patients with
full-blown heart failure die within 4 years [31]. Even the basic diagnosis, such as a detailed
interview and the use of electrocardiography, is enough to make an initial diagnosis of heart
failure,  which  is  confirmed  by observations  in  scientific  publications  on  this  topic  [32].
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Physical  activity  has  a  protective  effect  on the  risk  of  HF.  At  the  time  of  heart  failure,
properly selected activity is an important point of rehabilitation and should be used if there
are no contraindications [33]. Programs of multidisciplinary teams - treatment programs, can
reduce the mortality and morbidity of patients with heart failure [33]. HF treatment is based
on pharmacology. Research shows that the use of diuretics,  β-blockers and antagonists of
neurohormonal systems allow to extend the life of patients and improve their current conditio
[31]. An important factor in the management of HF is a diet that should limit salt, sugars and
saturated fats [34].
The information presented in specific chapters forms a whole that contains important
facts that play an important role for society due to the fact that heart failure is a disease with
poor prognosis and an important factor is prevention and therapeutic treatment in case of
having this disease.
Conclusions
Heart failure is a disease entity with a multifactorial etiology and often coexists with
other  diseases.  With age,  the number of patients  increases,  mainly  women get sick.  This
disease is the most common cause of hospitalization among geriatric patients. In assessing the
severity of changes, a four-level NYHA classification is most commonly used. Treatment
options  include  non-pharmacological,  pharmacological  and  surgical  treatment.  Physical
activity is important, which should be matched to the clinical condition of the patient and a
suitable diet with proven effectiveness, eg the Mediterranean diet.
A patient with heart failure should be put under the care of an interdisciplinary team,
thanks to which continuity of care is ensured and the prognosis improves.
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